Drug
Htx 011b
Htx 011b: highest development phase Phase 2, developed by Heron Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Heron Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| HTX-011B NCT02689258 | Phase 2 | Postoperative Pain |
Latest
No recent events.
Follow Htx 011b on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.